These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 20715855)

  • 21. Biochemical, pharmaceutical and therapeutic properties of long-acting lithocholic acid derivatized exendin-4 analogs.
    Chae SY; Jin CH; Shin JH; Son S; Kim TH; Lee S; Youn YS; Byun Y; Lee MS; Lee KC
    J Control Release; 2010 Mar; 142(2):206-13. PubMed ID: 19900495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of clusterin on pancreatic beta cell regeneration after exendin-4 treatment in neonatal streptozotocin administrated rats.
    Kaya-Dagistanli F; Ozturk M
    Acta Histochem; 2013 Jul; 115(6):577-86. PubMed ID: 23351716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation and structural, biochemical, and pharmaceutical characterizations of bile acid-modified long-acting exendin-4 derivatives.
    Son S; Chae SY; Kim CW; Choi YG; Jung SY; Lee S; Lee KC
    J Med Chem; 2009 Nov; 52(21):6889-96. PubMed ID: 19827752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human serum albumin-TRAIL conjugate for the treatment of rheumatoid arthritis.
    Byeon HJ; Min SY; Kim I; Lee ES; Oh KT; Shin BS; Lee KC; Youn YS
    Bioconjug Chem; 2014 Dec; 25(12):2212-21. PubMed ID: 25387356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DC3-decorated polyplexes for targeted gene delivery into dendritic cells.
    Golani-Armon A; Golan M; Shamay Y; Raviv L; David A
    Bioconjug Chem; 2015 Feb; 26(2):213-24. PubMed ID: 25560976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PEGylated human serum albumin (HSA) nanoparticles: preparation, characterization and quantification of the PEGylation extent.
    Fahrländer E; Schelhaas S; Jacobs AH; Langer K
    Nanotechnology; 2015 Apr; 26(14):145103. PubMed ID: 25789544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral delivery of an anti-diabetic peptide drug via conjugation and complexation with low molecular weight chitosan.
    Ahn S; Lee IH; Lee E; Kim H; Kim YC; Jon S
    J Control Release; 2013 Sep; 170(2):226-32. PubMed ID: 23747732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel mono-PEGylated dimeric GLP-1 conjugate with enhanced receptor activation and prolonged anti-diabetes efficacies.
    Li P; Zhang J; Jia Y; Zhang Y
    Life Sci; 2020 Aug; 254():117752. PubMed ID: 32387412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and characterization of a novel exendin-4 human serum albumin fusion protein expressed in Pichia pastoris.
    Huang YS; Chen Z; Chen YQ; Ma GC; Shan JF; Liu W; Zhou LF
    J Pept Sci; 2008 May; 14(5):588-95. PubMed ID: 17994612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stable Evans Blue Derived Exendin-4 Peptide for Type 2 Diabetes Treatment.
    Liu Y; Wang G; Zhang H; Ma Y; Lang L; Jacobson O; Kiesewetter DO; Zhu L; Gao S; Ma Q; Chen X
    Bioconjug Chem; 2016 Jan; 27(1):54-8. PubMed ID: 26641886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mono-PEGylates of exenatide in branched and dimeric structures can improve in vivo stability and hypoglycemic bioactivity.
    Thi Nguyen NT; Jung S; Lee SH; Bae ON; Lee EK
    J Biotechnol; 2019 Dec; 306():89-96. PubMed ID: 31580912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exendin-4, a glucagon-like peptide-1 analogue, accelerates diabetic wound healing.
    Roan JN; Cheng HN; Young CC; Lee CJ; Yeh ML; Luo CY; Tsai YS; Lam CF
    J Surg Res; 2017 Feb; 208():93-103. PubMed ID: 27993221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A site-specific PEGylated analog of exendin-4 with improved pharmacokinetics and pharmacodynamics in vivo.
    Gao M; Jin Y; Tong Y; Tian H; Gao X; Yao W
    J Pharm Pharmacol; 2012 Nov; 64(11):1646-53. PubMed ID: 23058052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long acting hyaluronate--exendin 4 conjugate for the treatment of type 2 diabetes.
    Kong JH; Oh EJ; Chae SY; Lee KC; Hahn SK
    Biomaterials; 2010 May; 31(14):4121-8. PubMed ID: 20149450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a neuromedin U-human serum albumin conjugate as a long-acting candidate for the treatment of obesity and diabetes. Comparison with the PEGylated peptide.
    Neuner P; Peier AM; Talamo F; Ingallinella P; Lahm A; Barbato G; Di Marco A; Desai K; Zytko K; Qian Y; Du X; Ricci D; Monteagudo E; Laufer R; Pocai A; Bianchi E; Marsh DJ; Pessi A
    J Pept Sci; 2014 Jan; 20(1):7-19. PubMed ID: 24222478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PEGylation of human serum albumin: reaction of PEG-phenyl-isothiocyanate with protein.
    Meng F; Manjula BN; Smith PK; Acharya SA
    Bioconjug Chem; 2008 Jul; 19(7):1352-60. PubMed ID: 18572961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-linked human serum albumin dimer has the potential for use as a plasma-retaining agent for the fatty acid-conjugated antidiabetic drugs.
    Taguchi K; Chuang VT; Yamasaki K; Urata Y; Tanaka R; Anraku M; Seo H; Kawai K; Maruyama T; Komatsu T; Otagiri M
    J Pharm Pharmacol; 2015 Feb; 67(2):255-63. PubMed ID: 25556343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemical Conjugation of Evans Blue Derivative: A Strategy to Develop Long-Acting Therapeutics through Albumin Binding.
    Chen H; Wang G; Lang L; Jacobson O; Kiesewetter DO; Liu Y; Ma Y; Zhang X; Wu H; Zhu L; Niu G; Chen X
    Theranostics; 2016; 6(2):243-53. PubMed ID: 26877782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Site-selective modification of exendin 4 with variable molecular weight dextrans by oxime-ligation chemistry for improving type 2 diabetic treatment.
    Dai S; Liu S; Li C; Zhou Z; Wu Z
    Carbohydr Polym; 2020 Dec; 249():116864. PubMed ID: 32933691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of PEGylated exendin-4 released from poly (lactic-co-glycolic acid) microspheres for antidiabetic therapy.
    Lim SM; Eom HN; Jiang HH; Sohn M; Lee KC
    J Pharm Sci; 2015 Jan; 104(1):72-80. PubMed ID: 25407390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.